Company intelligence / Profile preview
ChiaTai Qingchunbao Pharmaceutical
- Ownership
- Private
- Development stage
- Other
Overview
ChiaTai Qingchunbao Pharmaceutical is a China-based pharmaceutical company specializing in both modern small molecule drugs and traditional Chinese medicine. It has commercialized antibiotics such as sitafloxacin hydrate, conducts clinical research on cardiovascular therapies using herbal extracts, and develops oral TCM formulations with neuroprotective effects. The company is active with an estimated revenue of $400 million USD in 2024 and maintains a broad pipeline across infectious diseases, cardiovascular health, metabolic disorders, respiratory diseases, urogenital diseases, and nervous system disorders.
- Therapeutic areas
- CardiovascularInfectious DiseasesEndocrinology
- Modalities
- Small moleculeTraditional Chinese medicine preparations
- Industry
- Biotech
Drug pipeline
5 assets4 more assets in the full pipeline.
Partnerships
Beyond the preview
Go deeper on ChiaTai Qingchunbao Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ChiaTai Qingchunbao Pharmaceutical.